Preadmission beta-blocker use and 30-day mortality among patients in intensive care: a cohort study

INTRODUCTION: Beta-blockers have cardioprotective, metabolic and immunomodulating effects that may be beneficial to patients in intensive care. We examined the association between preadmission beta-blocker use and 30-day mortality following intensive care. METHODS: We identified 8,087 patients over...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Christensen, Steffen, Johansen, Martin Berg, Tønnesen, Else, Larsson, Anders, Pedersen, Lars, Lemeshow, Stanley, Sørensen, Henrik Toft
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2011
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3219345/
https://ncbi.nlm.nih.gov/pubmed/21385356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc10085
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak